Back to search

Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model

Data up to Jan 2025

Published2007
Citations55
References30

Total Citations Per Year

Abstract

References (30)

Guide for the Care and Use of Laboratory Animals

2011 • 15,863 citations

Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome

1989 • 6,910 citations

Van Damme A.

1986 • 3,477 citations

Hepatitis C Virus Infection

2001 • 2,979 citations

Hepatitis C

1994 • 1,906 citations

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1988 • 1,634 citations

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

2003 • 907 citations

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

2006 • 432 citations

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

2005 • 316 citations

Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034

2006 • 237 citations

Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons

2002 • 215 citations

Hepatitis C Virus Infection

2015 • 183 citations

A critical role for the chimpanzee model in the study of hepatitis C

2004 • 180 citations

Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro

2004 • 164 citations

Adaptive Mutations Producing Efficient Replication of Genotype 1a Hepatitis C Virus RNA in Normal Huh7 Cells

2004 • 125 citations

Characterization of the Inhibition of Hepatitis C Virus RNA Replication by Nonnucleosides

2003 • 123 citations

Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro

2005 • 120 citations

Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease Inhibitor

2005 • 104 citations

The Chimpanzee Model of Hepatitis C Virus Infections

2001 • 102 citations

Drug resistance in non-subtype B HIV-1

2003 • 94 citations

Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus

2007 • 59 citations

Mechanistic Study of HCV Polymerase Inhibitors at Individual Steps of the Polymerization Reaction

2006 • 43 citations

Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro

2007 • 38 citations

Replication efficiency of chimeric replicon containing NS5A–5B genes derived from HCV-infected patient sera

2006 • 35 citations

Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro

2006 • 33 citations

A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations

2007 • 31 citations

Treatment choices for people infected with HCV

2004 • 17 citations

Nonstructural protein 5B of hepatitis C virus.

2006 • 15 citations

Nonstructural Protein 5B of Hepatitis C Virus

2006 • 13 citations

Small Molecule and Biologic Inhibitors of Hepatitis C Virus: A Symbiotic Approach

2006 • 3 citations

Cited By (0)

No citing papers found in database

Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model (2007) – Antimicrobial Agents and Chemotherapy | Metascience Observatory Explorer